4//SEC Filing
Davis Blaine 4
Accession 0001209191-22-001715
CIK 0001359931other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:35 PM ET
Size
7.6 KB
Accession
0001209191-22-001715
Insider Transaction Report
Form 4
Davis Blaine
Chief Financial Officer
Transactions
- Award
Common Stock
2022-01-03+14,100→ 15,581 total - Award
Stock Option (Right to Buy)
2022-01-03+84,800→ 84,800 totalExercise: $6.90Exp: 2032-01-02→ Common Stock (84,800 underlying)
Footnotes (2)
- [F1]The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one-third installments on the first, second and third anniversaries of January 3, 2022.
- [F2]25% of the shares vest on the one year anniversary of January 3, 2022 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.
Documents
Issuer
Protara Therapeutics, Inc.
CIK 0001359931
Entity typeother
Related Parties
1- filerCIK 0001802188
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:35 PM ET
- Size
- 7.6 KB